Chapter 51: Bowel Disorder Drugs

Loading audio…

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

If there is an issue with this chapter, please let us know → Contact Us

Antidiarrheal medications are classified by mechanism: adsorbents such as bismuth subsalicylate and activated charcoal bind toxins and reduce intestinal irritation; anticholinergic agents decrease peristalsis through muscarinic receptor antagonism; opioid-based drugs including loperamide and diphenoxylate with atropine slow intestinal motility to allow increased water reabsorption; and probiotics restore normal microbial flora to support intestinal health. Each category carries distinct contraindications, adverse effects, and drug interactions requiring careful assessment. Laxative therapy encompasses five major classes with different mechanisms of action: bulk-forming agents increase stool volume and promote natural peristalsis; emollient laxatives soften stool consistency; hyperosmotic agents draw fluid into the colon to increase stool volume; saline laxatives produce osmotic effects through nonabsorbable salts; and stimulant laxatives directly enhance intestinal muscle contractions. The chapter addresses the clinical problem of opioid-induced constipation through peripherally acting opioid antagonists such as methylnaltrexone and naloxegol, which block opioid receptors in the gastrointestinal tract without affecting central pain relief. Irritable bowel syndrome management is divided into disease-specific pharmacotherapy: IBS with diarrhea is treated with agents like alosetron and rifaximin, while IBS with constipation responds to lubiprostone and linaclotide. Critical nursing responsibilities include comprehensive assessment of bowel patterns, fluid and electrolyte status, medication contraindications, and signs of laxative abuse. Patient education encompasses proper medication administration, adequate hydration, dietary fiber integration, recognition of warning symptoms such as hematochezia or severe abdominal pain, and lifestyle modifications supporting normal bowel function. The chapter integrates pharmacologic principles with clinical nursing judgment to optimize bowel disorder management while minimizing adverse effects and medication dependency.